Following two previous bariatric surgeries elsewhere, a 45-year-old woman undergoes a revision to a distal gastric bypass with outstanding results.
Attend the 12th Annual Cleveland Clinic Obesity Summit, Sept. 28-29, to hear about pharmacologic management, behavioral and lifestyle modification, and surgery.
Cleveland Clinic researchers are heading the first long-term study to evaluate the effectiveness of bariatric surgery compared with medical therapy for treating Type 2 diabetes.
Philip Schauer, MD, explains why the STAMPEDE trial’s five-year results and new ADA guidelines mean the pool of patients who may benefit from bariatric surgery is wider than you may suspect.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Watch Cleveland Clinic surgeon Philip Schauer, MD, demonstrate laparoscopic Roux-en-Y gastric bypass. He walks viewers through the essential steps, including jejunojejunostomy and gastrojejunostomy.
From new data on the causes of obesity to alternative treatments to new medications, join us for the latest insights at the 11th Annual Obesity Summit in Cleveland.
Are medication and lifestyle changes failing to get type 2 diabetes in control? New clinical guidelines make bariatric surgery a standard treatment option for diabetics with mild obesity.
In carefully selected adolescents with severe obesity, bariatric surgery is safe and effective and offers clinical and psychosocial benefits that can last a lifetime.
Five-year results from the pivotal STAMPEDE trial confirm those of interim reports, with bariatric surgery’s advantage over intensive medical therapy for diabetes appearing to widen over time.
Bariatric surgery has proven effective in improving diabetes or putting the disease into remission in obese patients, reducing dangerous cardiovascular risk factors.